BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.

MLA

Sang, Xu, et al. “BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.” Journal of Immunology Research, Aug. 2022, pp. 1–18. EBSCOhost, https://doi.org/10.1155/2022/7912484.

APA

Sang, X., Zhang, Y., Fang, F., Gao, L., Tao, Y., Li, X., Zhang, Z., Wang, J., Tian, Y., Li, Z., Yao, D., Wu, Y., Chu, X., Zhang, K., Ma, L., Lu, L., Chen, Y., Yu, J., Zhuo, R., & Wu, S. (2022). BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia. Journal of Immunology Research, 1–18. https://doi.org/10.1155/2022/7912484

Chicago

Sang, Xu, Yongping Zhang, Fang Fang, Li Gao, Yanfang Tao, Xiaolu Li, Zimu Zhang, et al. 2022. “BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.” Journal of Immunology Research, August, 1–18. doi:10.1155/2022/7912484.